News for 'US Department of Justice and Food and Drugs Administration'

US Justice Dept demands drug pricing info from Ranbaxy

US Justice Dept demands drug pricing info from Ranbaxy

Rediff.com17 Sep 2014

The company has received a Civil Investigative Demand from the US Department of Justice, Ranbaxy Laboratories said in a filing to the BSE.

Maha portfolio allocation: Fadnavis gets Home, Ajit Finance, Shinde...

Maha portfolio allocation: Fadnavis gets Home, Ajit Finance, Shinde...

Rediff.com21 Dec 2024

Shiv Sena's Dadaji Bhuse is the new school education minister while Uday Samant continues to be the industries minister.

The Many Portfolios Of Yogi Adityanath

The Many Portfolios Of Yogi Adityanath

Rediff.com4 Apr 2022

In his second term in office, UP Chief Minister Yogi Adityanath has retained 34 portfolios.

Trump picks anti-vaccine activist as health secretary

Trump picks anti-vaccine activist as health secretary

Rediff.com15 Nov 2024

President-elect Donald Trump announced a slate of key Cabinet nominations, including tapping former Democratic presidential candidate Robert F. Kennedy Jr. as his Secretary of Health and Human Services and former Congressman Doug Collins of Georgia as Secretary for Veterans Affairs. Trump also named Jay Clayton as US Attorney for the Southern District of New York, Todd Blanche as Deputy Attorney General, and Dean John Sauer as Solicitor General of the United States.

Daiichi was given all updates: Malvinder Singh

Daiichi was given all updates: Malvinder Singh

Rediff.com24 May 2013

Singh says Japanese pharma giant's allegations false.

Ranbaxy settles case with USFDA, to pay $500 mn

Ranbaxy settles case with USFDA, to pay $500 mn

Rediff.com21 Dec 2011

Drug-maker Ranbaxy Laboratories on Wednesday said it has signed an agreement with the US health regulator to lift a ban on the import of drugs from certain manufacturing plants in India and will pay up to $500 million to settle a case lodged by the Department of Justice.

Daiichi pursuing legal action on ex-shareholders

Daiichi pursuing legal action on ex-shareholders

Rediff.com23 May 2013

Says former Ranbaxy owners concealed critical information on probe by US agencies.

US drops legal action against Ranbaxy

US drops legal action against Ranbaxy

Rediff.com10 Oct 2008

Ranbaxy's shares jumped almost 10 per cent, having long been depressed by escalating investigations from the US Food and Drug Administration, triggering a ban, which is still in place, that stops the US importing or purchasing the company's drugs. Daiichi Sankyo, the Japanese drugmaker, reiterated on Wednesday that it would stick to its June offer to buy Ranbaxy in spite of its recent troubles.

Why Daiichi is taking Malvinder Singh to court

Why Daiichi is taking Malvinder Singh to court

Rediff.com27 Nov 2013

The Japanese company alleges the earlier Ranbaxy promoters withheld crucial information when they sold the company in 2008.

Ranbaxy to pay heavily for future US violations

Ranbaxy to pay heavily for future US violations

Rediff.com27 Jan 2012

Ranbaxy has also agreed to relinquish any 180-day marketing exclusivity that it might have for three pending generic drug applications.

Rs 3,500-cr fine on Singh bros, not Rs 2,562 cr: Daiichi

Rs 3,500-cr fine on Singh bros, not Rs 2,562 cr: Daiichi

Rediff.com7 May 2016

Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy

Former Ranbaxy promoters fined Rs 2,600 crore

Former Ranbaxy promoters fined Rs 2,600 crore

Rediff.com5 May 2016

The US arm of Ranbaxy pleaded guilty to seven felonies relating to the manufacture and distribution of certain adulterated drugs

Ranbaxy loses exclusivity on heartburn drug in US

Ranbaxy loses exclusivity on heartburn drug in US

Rediff.com28 Jan 2015

FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain

Ajit Pawar and men win big, Shinde and Co lose out in Maharashtra portfolios

Ajit Pawar and men win big, Shinde and Co lose out in Maharashtra portfolios

Rediff.com14 Jul 2023

Nationalist Congress Party leader Ajit Pawar was given the finance and planning portfolio on Friday, nearly two weeks after he broke away from the original party and took oath as Maharashtra's deputy chief minister.

Ranbaxy drugs cleared FDA test before import alert

Ranbaxy drugs cleared FDA test before import alert

Rediff.com11 Jun 2013

FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.

Maha portfolios: Sena gets home, NCP finance, Cong revenue

Maha portfolios: Sena gets home, NCP finance, Cong revenue

Rediff.com13 Dec 2019

Portfolios were distributed 2 weeks after the MVA govt was sworn-in. Shiv Sena's Eknath Shinde will be home minister while NCP's Jayant Patil will be finance minister.

Fadnavis allocates portfolios; BJP retains key depts

Fadnavis allocates portfolios; BJP retains key depts

Rediff.com6 Dec 2014

Maharashtra Chief Minister Devendra Fadnavis on Saturday allocated portfolios to the twenty-member council of ministers, including 10 of the Shiv Sena, who were inducted into his expanded cabinet.

Maha portfolios: Ajit Pawar gets finance; Aaditya tourism

Maha portfolios: Ajit Pawar gets finance; Aaditya tourism

Rediff.com5 Jan 2020

With this allocation of portfolios, the Sharad Pawar-led NCP has got most of the 'plum' ministries.

Fadnavis gets home, finance; BJP bags key portfolios in Maha cabinet

Fadnavis gets home, finance; BJP bags key portfolios in Maha cabinet

Rediff.com14 Aug 2022

Five days after the induction of 18 ministers into his cabinet, Maharashtra Chief Minister Eknath Shinde on Sunday allocated portfolios, keeping Urban Development and 11 other ministries with himself, while giving the crucial Home Department to Deputy CM Devendra Fadnavis.

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

Rediff.com24 Jun 2013

FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.

The mistakes Daiichi Sankyo made in the Ranbaxy deal

The mistakes Daiichi Sankyo made in the Ranbaxy deal

Rediff.com12 May 2016

The FDA actions eventually led to a $500-million fine for Ranbaxy as well as the effective mothballing of many of its Indian factories.

Another big blow for Ranbaxy

Another big blow for Ranbaxy

Rediff.com22 Aug 2014

Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.

Ranbaxy hires BCG, Mercer for internal strategic project

Ranbaxy hires BCG, Mercer for internal strategic project

Rediff.com1 Jun 2013

Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.

Regulator might inspect Wockhardt units

Regulator might inspect Wockhardt units

Rediff.com12 Jun 2013

Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Rediff.com6 May 2016

In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.

The A-W Of Desi Guests At the White House Dinner

The A-W Of Desi Guests At the White House Dinner

Rediff.com24 Jun 2023

The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.

Ranbaxy's top executives in the US resign

Ranbaxy's top executives in the US resign

Rediff.com14 Oct 2014

US country head, key departmental heads leave; more likely to follow.

Daiichi drags Malvinder to Singapore court

Daiichi drags Malvinder to Singapore court

Rediff.com12 Nov 2013

In 2008, Daiichi Sankyo had bought the entire 34.82 per cent stake in Ranbaxy from its promoters, Malvinder Mohan Singh and family, for $4.2 billion. Currently, Singh is executive chairman of Fortis Healthcare.

Don't need to sell assets, can pay fine: Ranbaxy brothers

Don't need to sell assets, can pay fine: Ranbaxy brothers

Rediff.com25 May 2016

In 2013, Daiichi had launched the arbitration proceedings in Singapore.

Daiichi-Ranbaxy row: HC orders attachment of assets

Daiichi-Ranbaxy row: HC orders attachment of assets

Rediff.com26 Feb 2018

The court also restrained RHC Holdings from operating its bank accounts except for payment of salaries and statutory dues till March 23, the next date of hearing.

'My job is not to represent the world; my job is to represent the United States of America'

'My job is not to represent the world; my job is to represent the United States of America'

Rediff.com1 Mar 2017

The following is the full text of US President Donald Trump's first address to a joint session of the Congress on February 28, as prepared for delivery and released by the White House press office.

'But who do we blame? Who do we beat up? Doctors!'

'But who do we blame? Who do we beat up? Doctors!'

Rediff.com24 Mar 2017

A resident doctor, working at a government hospital, upset by the poor response from the state government, offers his side of the story.

Can Nitish escape blame for Muzaffarpur scandal?

Can Nitish escape blame for Muzaffarpur scandal?

Rediff.com20 Aug 2018

'These children are wards of the State. They were exploited because the state government and its officials didn't do their jobs.'

The A to Z of 2020

The A to Z of 2020

Rediff.com31 Dec 2020

We present our alphabet of 2020, pulling in everything you'll remember about this year we'd rather forget.

2018: Year of reckoning for India Inc

2018: Year of reckoning for India Inc

Rediff.com28 Dec 2018

A glance back at some of the important ups and down Indian Inc faced in 2018.

Mid-day meal tragedy exposes poor state of Bihar

Mid-day meal tragedy exposes poor state of Bihar

Rediff.com22 Jul 2013

The buck for the Gandamal tragedy should not stop with the school-in-charge Meena Kumari. She is just the face of a deeper malaise in Bihar, says Apoorvanand.